ResearchIn-Press PreviewImmunology Open Access | 10.1172/jci.insight.186000
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Kumar, A. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Das, J. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Peng, H. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Wang, L. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Ballard, D. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Ren, Y. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Xiong, X. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Ren, X. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Yang, J. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by de Figueiredo, P. in: JCI | PubMed | Google Scholar
1Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, United States of America
2Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, United States of America
3Department of Molecular Microbiology and Immunology, The University of Missouri School of Medicine, Columbia, United States of America
Find articles by Song, J. in: JCI | PubMed | Google Scholar |
Published January 7, 2025 - More info
The nucleus accumbens-associated protein-1 (NAC1) has recently emerged as a pivotal factor in oncogenesis by promoting glycolysis. Deletion of NAC1 in regulatory T cells (Tregs) has been shown to enhance FoxP3 stability, a suppressor of glycolysis. This study delves into the intriguing dual role of NAC1, uncovering that Tregs-specific deletion of NAC1 fosters metabolic fitness in Tregs, thereby promoting tumorigenesis. Our results unveil that NAC1-deficient Tregs exhibit prolonged survival and heightened function, particularly in acidic environments. Mechanistically, we find that NAC1-deficient Tregs adapt to adverse conditions by upregulating FoxP3 expression, engaging in CD36-mediated lipid metabolism, and enhancing PGC-1α-regulated mitochondrial function. In mouse tumor xenograft models, NAC1-deficient mice demonstrate increased susceptibility to tumor growth. Notably, Tregs lacking NAC1 not only display elevated lipid metabolism and mitochondrial fitness but also exhibit enhanced tumoral infiltration. Adoptive Treg transfer experiments further underscore the supportive role of NAC1-deficient Tregs in tumor growth. These findings suggest that modulating NAC1 expression in FoxP3+ Tregs could serve as a promising approach to augment antitumor immunity. Understanding the intricate interplay between NAC1 and Tregs opens avenues for potential therapeutic strategies targeting the tumor microenvironment (TME).